Cargando…
Neuroprotective Effect of IRL-1620, an Endothelin B Receptor Agonist, on a Pediatric Rat Model of Middle Cerebral Artery Occlusion
Objective: The purpose of this study was to determine the potential neuroprotective effect of endothelin B (ET(B)) receptor agonist IRL-1620 treatment in a pediatric model of ischemic stroke. Design: A prospective, animal model study. Setting: An experimental laboratory. Subjects: Three-month-old ma...
Autores principales: | Cifuentes, Enrique G., Hornick, Mary G., Havalad, Suresh, Donovan, Ramona L., Gulati, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206019/ https://www.ncbi.nlm.nih.gov/pubmed/30406063 http://dx.doi.org/10.3389/fped.2018.00310 |
Ejemplares similares
-
Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2019) -
Author Correction: Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2020) -
Attenuation of opioid tolerance by ET(B) receptor agonist, IRL-1620, is independent of an accompanied decrease in nerve growth factor in mice
por: Gulati, Shruti, et al.
Publicado: (2017) -
Sovateltide (IRL-1620) activates neuronal differentiation and prevents mitochondrial dysfunction in adult mammalian brains following stroke
por: Ranjan, Amaresh K., et al.
Publicado: (2020) -
The endothelin B (ET(B)) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification
por: Cemazar, M, et al.
Publicado: (2005)